Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-98528; File No. SR-PHLX-2023-40]

      ( print page 67846)    
                    On August 28, 2023, Nasdaq PHLX LLC (“Phlx” or “Exchange”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to amend Equity 4, Rules 3301A and 3301B [3]                                          to establish new “Contra Midpoint Only” and “Contra Midpoint Only with Post-Only” Order Types, and to make other corresponding changes to the Rulebook. The proposed rule change was published for comment in the                     **Federal Register**                     on September 8, 2023.[4]                                          The Commission received no comments on the proposed rule change.                

                    Section 19(b)(2) of the Act [5]                                          provides that within 45 days of the publication of notice of the filing of a proposed rule change, or within such longer period up to 90 days (i) as the Commission may designate if it finds such longer period to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents, the Commission shall either approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether the proposed rule change should be disapproved. The 45th day after publication of the notice for this proposed rule change is October 23, 2023. The Commission is extending this 45-day time period.                

                    The Commission finds that it is appropriate to designate a longer period within which to take action on the proposed rule change so that it has sufficient time to consider the proposed rule change. Accordingly, pursuant to Section 19(b)(2) of the Act,[6]                                          the Commission designates December 7, 2023, as the date by which the Commission shall either approve or disapprove, or institute proceedings to determine whether to disapprove, the proposed rule change (File No. SR-PHLX-2023-40).                

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[7] 

Sherry R. Haywood,

Assistant Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                             References herein to Phlx Rules in the 3000 Series shall mean Rules in Phlx Equity 4.                    
        Back to Citation      

4.                                                     *See*                         Securities Exchange Act Release No. 98280 (September 1, 2023), 88 FR 62129.                    
        Back to Citation      

5.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

6.                                                     *Id.*
        Back to Citation      

7.                                 17 CFR 200.30-3(a)(31).                        
        Back to Citation      

[FR Doc. 2023-21619 Filed 9-29-23; 8:45 am]

BILLING CODE 8011-01-P